SG Americas Securities
CASI icon

SG Americas Securities’s CASI Pharmaceuticals CASI Stock Holding History

SG Americas Securities’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,937
Closed -$73K – 2776
2020
Q2 		$73K Buy
2,937
+1,110
+61% +$24.1K ﹤0.01% 3463
2020
Q1 		$37K Buy
+1,827
New +$43.6K ﹤0.01% 3221

Other funds holding CASI

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SG Americas Securities's CASI Position: Q3 2020 in Review

SG Americas Securities sold out of CASI Pharmaceuticals (CASI) in Q3 2020, closing a stake of 2,937 shares — an estimated $73K sold.

SG Americas Securities first reported a position in CASI in Q1 2020 and held it in 2 quarters. The position peaked at $73K in Q2 2020. 67 funds tracked by Wall St. Rank hold CASI as of Q3 2020.

  • SG Americas Securities reported no remaining CASI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 2,937 CASI Pharmaceuticals shares in Q3 2020, an estimated $73K.
  • SG Americas Securities first reported a position in CASI Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • SG Americas Securities's CASI Pharmaceuticals position peaked at $73K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.